METTL3 is required for maintaining β-cell function

Xinzhi Li,Yuze Jiang,Xu Sun,Yongsen Wu,Zheng Chen
DOI: https://doi.org/10.1016/j.metabol.2021.154702
IF: 13.934
2021-03-01
Metabolism
Abstract:<p>N6-methyladenosine (m<sup>6</sup>A) mRNA methylation has been shown to regulate obesity and type 2 diabetes. However, whether METTL3, the key methyltransferase for m<sup>6</sup>A mRNA methylation, regulates β-cell failure in diabetes has not been fully explored. Here, we show that METTL3 is downregulated under the inflammatory and oxidative stress conditions, and islet β-cell-specific deletion of <em>Mettl3</em> induces β-cell failure and hyperglycemia, which is likely due to decreased m<sup>6</sup>A modification and reduced expression of insulin secretion-related genes. Overall, METTL3 might be a potential drug target for the treatment of β-cell failure in diabetes.</p>
endocrinology & metabolism
What problem does this paper attempt to address?